Skip to main content
. 2022 Nov 28;10(12):2030. doi: 10.3390/vaccines10122030

Figure 2.

Figure 2

Main actions of the NPIP and milestones of evolution of influenza vaccination in Poland, *-50% reimbursement of influenza vaccine for patients aged 65–74 years old and 100% reimbursement for patients ≥75 years old; **-50% reimbursement of influenza vaccine for patients aged 18–64 years old from risk groups, pregnant women, and children aged 2–5 years old.